 |
市場調查報告書
商品編碼
1897633
分叉血管支架市場規模、佔有率和成長分析（按器械類型、材質、應用和地區分類）－2026-2033年產業預測Branched Stent Grafts Market Size, Share, and Growth Analysis, By Device Type (Aortic Branched Stent Grafts, Iliac Branched Stent Grafts), By Material (Nitinol, Polytetrafluoroethylene (PTFE)), By Application, By Region - Industry Forecast 2026-2033 |
||||||
全球分叉血管支架市場規模預計在 2024 年達到 3.4937 億美元，從 2025 年的 3.7627 億美元成長到 2033 年的 6.8112 億美元，在預測期（2026-2033 年）內複合年成長率為 7.7%。
由於醫療技術的進步、血管內介入治療（EVAR）手術量的增加以及患者照護品質的提高，全球分支血管支架市場正經歷顯著成長。人口老化加劇以及主動脈瘤和腹部主動脈血管瘤的高發生率進一步推動了市場擴張。此外，微創手術技術的普及也為市場發展提供了巨大機會。儘管全球衛生危機期間擇期手術的延遲等醫療服務中斷帶來了挑戰，但對分支血管支架的整體需求仍在持續成長。這項創新技術拓展了主動脈病變的治療範圍，凸顯了其在現代血管介入治療中的關鍵作用，使其在未來的醫療保健領域擁有強勁的成長潛力。
推動全球分支血管支架市場發展的因素
分支型血管支架市場受到血管內動脈瘤修復術（EVAR）數量不斷增加、患者照護品質不斷提高以及醫療技術持續進步的顯著影響。此外，人口老化和腹部主動脈血管瘤（AAA）發生率上升也促進了該市場的擴張。這些因素共同推動了血管疾病治療領域對創新解決方案的強勁需求，進而推動了全球分支型血管支架市場的成長與發展。隨著醫療保健的不斷發展，該市場有望迎來進一步的進步和更廣泛的應用。
限制全球分支支架血管支架市場的因素
全球分支血管支架市場面臨嚴峻挑戰，主要原因是血管內動脈瘤修復手術費用高。這一經濟障礙限制了中低收入患者獲得治療的機會，使他們難以負擔必要的治療費用。由於相當一部分人群無法獲得先進的醫療干預，這些手術的高昂費用成為市場成長的主要阻礙因素。因此，這種限制性的價格動態阻礙了分支血管支架在血管疾病治療中的廣泛應用，進而影響了整體市場潛力。
分支支架血管支架市場的全球趨勢
全球分支血管支架市場呈現顯著上升趨勢，這主要得益於血管疾病盛行率的不斷攀升以及微創手術技術的日益普及。腹主動脈瘤腔內修復術（AEVAR）、分支血管瘤腔內修復術（BEVAR）和胸主動脈瘤腔內修復術（TEVAR）等治療方法因其安全性、有效性、成本效益以及顯著縮短手術時間的優勢而備受關注。包括X光在內的先進影像引導技術的應用，提高了手術精度和治療效果，進一步推動了市場成長。隨著患者意識的不斷提高和技術的進步，分支血管支架市場前景仍然強勁且充滿希望。
目錄
介紹
- 調查目標
- 調查範圍
- 定義
調查方法
- 資訊收集
- 二手資料和一手資料方法
- 市場規模預測
- 市場假設與限制
執行摘要
- 全球市場展望
- 供需趨勢分析
- 細分市場機會分析
市場動態與展望
- 市場規模
- 市場動態
- 促進因素和機遇
- 限制與挑戰
- 波特分析
關鍵市場考察
- 關鍵成功因素
- 競爭程度
- 關鍵投資機會
- 市場生態系統
- 市場吸引力指數（2025）
- PESTEL 分析
- 總體經濟指標
- 價值鏈分析
- 定價分析
- 監管分析
全球分支支架血管支架市場規模（按器械類型和複合年成長率分類）（2026-2033 年）
- 主動脈分叉血管支架
- 髂動脈分叉支架血管支架
- 股動脈分支血管支架
- 全球分支支架血管支架市場規模（按材料和複合年成長率分類）（2026-2033 年）
- 鎳鈦諾
- 聚四氟乙烯（PTFE）
- 聚酯纖維
全球分支支架血管支架市場規模（按應用及複合年成長率分類）（2026-2033 年）
- EVAR
- 煙囪
- 開窗式血管內主動脈瘤修復術
- 其他
全球分支支架血管支架市場規模及複合年成長率（2026-2033）
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
- 亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
- 拉丁美洲
- 巴西
- 其他拉丁美洲地區
- 中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區
競爭資訊
- 前五大公司對比
- 主要企業的市場定位（2025 年）
- 主要市場參與者所採取的策略
- 近期市場趨勢
- 公司市佔率分析（2025 年）
- 主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較
主要企業簡介
- Medtronic plc
- Cook Medical
- WL Gore & Associates, Inc.
- Endologix, Inc.
- JOTEC GmbH
- LeMaitre Vascular, Inc.
- MicroPort Scientific Corporation
- Terumo Corporation
- Vascutek, Ltd.
- Zenith（Cook Medical）
- TriVascular Technologies, Inc.
- Bolton Medical
- Lombard Medical, Inc.
- QualiMed Innovative Medizinprodukte GmbH
- Nano Endoluminal, SL
結論與建議
Global Branched Stent Grafts Market size was valued at USD 349.37 Million in 2024 and is poised to grow from USD 376.27 Million in 2025 to USD 681.12 Million by 2033, growing at a CAGR of 7.7% during the forecast period (2026-2033).
The global branched stent graft market is experiencing significant growth driven by advancements in medical technology, an increase in endovascular cardiovascular disease repair (EVAR) procedures, and enhanced patient care quality. The rise in the elderly population and the high incidence of aortic and abdominal aneurysms are further fueling market expansion. Additionally, the trend toward minimally invasive surgical techniques presents considerable opportunities for market development. Despite challenges posed by disruptions in healthcare services, such as postponed elective surgeries during global health crises, the overall demand for branched stent grafts continues to rise. This innovative technology expanding the treatment scope for aortic lesions underscores its critical role in modern vascular interventions, positioning it strongly for future growth within the healthcare landscape.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Branched Stent Grafts market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Branched Stent Grafts Market Segments Analysis
Global Branched Stent Grafts Market is segmented by device type, material, application and region. Based on device type, the market is segmented into aortic branched stent grafts, iliac branched stent grafts and femoral branched stent grafts. Based on material, the market is segmented into nitinol, polytetrafluoroethylene (PTFE) and polyester. Based on application, the market is segmented into EVAR, chimney, fenestrated endovascular aortic aneurysm repair and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Branched Stent Grafts Market
The branched stent grafts market is significantly influenced by an increase in endovascular aneurysm repair (EVAR) procedures, enhancements in the quality of patient care, and the ongoing advancements in medical technology. Additionally, the aging population and the rising incidence of abdominal aortic aneurysms (AAA) are contributing to the expansion of this market. These factors collectively create a strong demand for innovative solutions in the treatment of vascular conditions, thereby propelling the growth and development of branched stent grafts within the global medical landscape. As healthcare continues to evolve, the market is poised for further advancements and increased adoption.
Restraints in the Global Branched Stent Grafts Market
The global branched stent grafts market faces notable challenges due to the high costs associated with endovascular aneurysm repair procedures. This financial barrier limits access for individuals from middle and lower-income backgrounds, making it difficult for them to afford the necessary treatments. The significant expenses involved in these procedures serve as a substantial constraint on market growth, as a considerable segment of the population is unable to pursue advanced medical interventions. Consequently, the restrictive pricing dynamics hinder wider adoption and utilization of branched stent grafts in treating vascular ailments, impacting overall market potential.
Market Trends of the Global Branched Stent Grafts Market
The Global Branched Stent Grafts market is witnessing a notable upward trend, driven by the increasing prevalence of vascular diseases and the growing acceptance of minimally invasive surgical techniques. Treatments such as abdominal endovascular aneurysm repair (AEVAR), branched endovascular aneurysm repair (BEVAR), and thoracic endovascular aneurysm repair (TEVAR) have gained prominence due to their safety, efficacy, and cost-effectiveness, significantly reducing operative times. The integration of advanced imaging guidance technologies, including X-rays, enhances procedural accuracy and outcomes, further propelling market growth. As patient awareness and technological advancements continue to rise, the outlook for branched stent grafts remains robust and promising.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2025
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
- Regulatory Analysis
Global Branched Stent Grafts Market Size by Device Type & CAGR (2026-2033)
- Market Overview
- Aortic Branched Stent Grafts
- Iliac Branched Stent Grafts
- Femoral Branched Stent Grafts
- Global Branched Stent Grafts Market Size by Material & CAGR (2026-2033)
- Market Overview
- Nitinol
- Polytetrafluoroethylene (PTFE)
- Polyester
Global Branched Stent Grafts Market Size by Application & CAGR (2026-2033)
- Market Overview
- EVAR
- Chimney
- Fenestrated Endovascular Aortic Aneurysm Repair
- Others
Global Branched Stent Grafts Market Size & CAGR (2026-2033)
- North America (Device Type, Material, Application)
- US
- Canada
- Europe (Device Type, Material, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Device Type, Material, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Device Type, Material, Application)
- Brazil
- Rest of Latin America
- Middle East & Africa (Device Type, Material, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)
Key Company Profiles
- Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cook Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- W. L. Gore & Associates, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Endologix, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- JOTEC GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LeMaitre Vascular, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MicroPort Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vascutek, Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Zenith (Cook Medical)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- TriVascular Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bolton Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lombard Medical, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- QualiMed Innovative Medizinprodukte GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nano Endoluminal, S.L.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
主動脈血管支架市場規模、佔有率和成長分析（按產品、最終用戶和地區分類）—產業預測（2026-2033 年）
自動擴張型支架：全球市場佔有率和排名、總收入和需求預測（2025-2031年）
全球支架置入和擴張器材市場：市場規模、佔有率和趨勢分析（2025-2032 年）
主動脈血管支架市場（依動脈瘤部位、移植物類型、配置、植入機制、最終用戶、入路和材料分類）－2025-2032年全球預測血管支架市場按產品類型、適應症、最終用戶、輸送機制、材料和配置分類－2025-2032 年全球預測
主動脈支架移植物市場
2025年主動脈血管支架全球市場報告2025年全球主動脈內皮移植市場報告2025年全球自膨式支架市場報告
全球自動擴張型支架市場